Variant report
Variant | nsv564073 |
---|---|
Chromosome Location | chr14:26030013-26057695 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191708798 | chr14:26031688-26031689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370568600 | chr14:26031713-26031714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532029389 | chr14:26031715-26031716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548631015 | chr14:26031735-26031736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568450056 | chr14:26031816-26031817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373256398 | chr14:26031838-26031839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562445303 | chr14:26031867-26031868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112584455 | chr14:26031868-26031869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77112547 | chr14:26031878-26031879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs199954666 | chr14:26031879-26031880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs118034847 | chr14:26031881-26031882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12894028 | chr14:26031882-26031883 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs562119536 | chr14:26031927-26031928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570963442 | chr14:26031930-26031931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183672163 | chr14:26031966-26031967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556316925 | chr14:26032007-26032008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569795227 | chr14:26032017-26032018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188146916 | chr14:26032022-26032023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141750149 | chr14:26032026-26032027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571671692 | chr14:26032047-26032048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529979932 | chr14:26032057-26032058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371353002 | chr14:26032066-26032067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534834903 | chr14:26032083-26032084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573894193 | chr14:26032084-26032085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147099464 | chr14:26032086-26032087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569992719 | chr14:26032096-26032097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537225995 | chr14:26032100-26032101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577676347 | chr14:26032101-26032102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs28507897 | chr14:26032153-26032154 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs77833049 | chr14:26032162-26032163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs138485174 | chr14:26032170-26032171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542507734 | chr14:26032196-26032197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562391807 | chr14:26032210-26032211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527640616 | chr14:26032218-26032219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191823810 | chr14:26032231-26032232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547824246 | chr14:26032252-26032253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570901836 | chr14:26032255-26032256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533461755 | chr14:26032327-26032328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1955878 | chr14:26032329-26032330 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs80207755 | chr14:26032331-26032332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570451109 | chr14:26032363-26032364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556088737 | chr14:26044873-26044874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560779512 | chr14:26044886-26044887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577611141 | chr14:26044924-26044925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182189150 | chr14:26044940-26044941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs35675501 | chr14:26044962-26044963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546548147 | chr14:26045058-26045059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562855660 | chr14:26045073-26045074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531759471 | chr14:26045103-26045104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577627315 | chr14:26045106-26045107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
severe speech impairment | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Cancer | 21183584 | CNVD |
Leukoplakia | 24403051 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic myeloid leukemia | 16756668 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:26031600-26032400 | Enhancers | Adipose Nuclei | Adipose |
2 | chr14:26044800-26046600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr14:26045000-26045600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr14:26045000-26046600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr14:26045200-26046200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr14:26045200-26046600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr14:26045400-26046400 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr14:26045400-26046400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr14:26045600-26046000 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
10 | chr14:26045600-26046600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr14:26046000-26046600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr14:26055400-26055600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr14:26055600-26061400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |